(Yicai Global) Dec. 26 -- Shanghai Kaibao Pharmaceutical Co. [SHE:300039] has achieved a breakthrough in researching and developing ways to fight drug resistant bacteria with traditional Chinese medicine.

Tanreqing Injection, which Shanghai Kaibao Pharmaceutical developed, can prevent the formation of biofilms in certain drug resistant bacteria and can damage ones that already formed, depriving the bacteria of their resistance, academician Li Lianda of CACMS's Experimental Research Center said in Shanghai on Dec. 23, citing a drug efficacy study that an expert team from the Experimental Research Center of China Academy of Chinese Medical Sciences conducted.

Since 2016, that expert team has carried out various studies on TCM Tanreqing Injection including the drug efficacy study, research on bacteria's drug resistance mechanisms, a comparative study between Tanreqing Injection and other similar drugs, and a drug combination study.

Methicillin-resistant Staphylococcus aureus is prevalent in the study of drug-resistant bacteria. For certain antibiotics, Tanreqing Injection can reverse anti-MRSA activity, and its combination with vancomycin can effectively prolong the duration of its efficacy, the research report said.

Tanreqing Injection's active ingredients can traverse the blood-brain barrier, and this specific mechanism is under further exploration, the study said.

The research results have offered new thoughts for the control and clinical treatment of drug resistant bacteria and infectious diseases, and will have a significant impact on the clinical application of Tanreqing Injection, boosting the progress of research into the resistant mechanism of anti-drug bacteria and pushing forward its clinical application in the TCM sector.

Drug resistant bacteria that appeared after the abuse of antibiotics seriously threaten human health and have become a focus and challenge of the medical world.